Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ORPH.L (ORPH) Regulatory News

Date Source Headline
9th Mar 2022 4:41 pm RNS Second Price Monitoring Extn
9th Mar 2022 4:37 pm RNS Price Monitoring Extension
8th Mar 2022 7:00 am RNS Trading Update and screening facilities expansion
7th Mar 2022 2:06 pm RNS Second Price Monitoring Extn
7th Mar 2022 2:00 pm RNS Price Monitoring Extension
7th Mar 2022 11:06 am RNS Second Price Monitoring Extn
7th Mar 2022 11:00 am RNS Price Monitoring Extension
2nd Mar 2022 7:00 am RNS Investor Presentations
24th Feb 2022 7:00 am RNS CEO Appointment
22nd Feb 2022 7:00 am RNS FDA Breakthrough Designation for Big Pharma RSV
17th Feb 2022 12:05 pm RNS Positive results from RSV Human Challenge Study
14th Feb 2022 7:00 am RNS Launch of STRiVE project
2nd Feb 2022 7:00 am RNS World’s first COVID-19 Characterisation Study
26th Jan 2022 4:40 pm RNS Second Price Monitoring Extn
26th Jan 2022 4:36 pm RNS Price Monitoring Extension
20th Jan 2022 7:00 am RNS Malaria Human Challenge Model Launched
21st Dec 2021 7:00 am RNS £5m Influenza human challenge study contract win
16th Dec 2021 4:41 pm RNS Second Price Monitoring Extn
16th Dec 2021 4:35 pm RNS Price Monitoring Extension
10th Dec 2021 11:05 am RNS Second Price Monitoring Extn
10th Dec 2021 11:00 am RNS Price Monitoring Extension
10th Dec 2021 7:05 am RNS Exercise of Options
10th Dec 2021 7:00 am RNS $13.4m Influenza HCS contract win
6th Dec 2021 7:00 am RNS Positive results from Flu Human Challenge Study
19th Nov 2021 7:00 am RNS Imutex Vaccine Phase I Study Results
17th Nov 2021 7:00 am RNS £5.1m RSV contract
15th Nov 2021 7:00 am RNS £1.5m Contract renewal for Venn Life Sciences
13th Oct 2021 7:00 am RNS Directorate Change
20th Sep 2021 7:00 am RNS Half-year Report
20th Sep 2021 7:00 am RNS £5.7m Influenza human challenge study contract win
9th Sep 2021 7:00 am RNS Notice of Results
7th Sep 2021 7:00 am RNS Positive results from RSV Human Challenge Study
24th Aug 2021 9:05 am RNS Second Price Monitoring Extn
24th Aug 2021 9:00 am RNS Price Monitoring Extension
24th Aug 2021 7:00 am RNS £8.1m Asthma Human Challenge Study Contract Win
9th Aug 2021 7:00 am RNS Malaria Human Challenge Model
29th Jul 2021 7:00 am RNS DNDi Phase II trial support
22nd Jul 2021 7:00 am RNS NEJM Opinion Piece
21st Jul 2021 12:58 pm RNS Result of AGM
14th Jul 2021 9:06 am RNS Directors’ Dealings
FTSE 100 Latest
Value8,809.74
Change53.53